Clinical Trial Update: Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 [Phase 3]

View source ↗

Summary

Autopsy follow-up data from subjects previously imaged with Florbetapir F-18 PET in the Phase 3 trial 18F-AV-45-A07 for Alzheimer's disease have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-05-07